SEC Form 4 · accession 0001127602-15-022968
CVS HEALTH Corp · CVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lisa Bisaccia
Officer — EVP, Chief HR Officer
Period of report
Jul 15, 2015
Accepted (ET)
Jul 16, 2015 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000064803
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 15, 2015 | S | 7,926 | $110.00 | D | 21,003 | D | |
| Common Stock | Jul 15, 2015 | M | 6,884 | $54.53 | A | 27,887 | D | |
| Common StockF2 | Jul 15, 2015 | S | 6,884 | $110.01 | D | 21,003 | D | |
| Common Stock | Jul 15, 2015 | M | 6,884 | $54.53 | A | 27,887 | D | |
| Common StockF3 | Jul 15, 2015 | S | 6,884 | $110.00 | D | 21,003 | D | |
| Common Stock | Jul 15, 2015 | M | 8,392 | $74.29 | A | 29,395 | D | |
| Common StockF3 | Jul 15, 2015 | S | 8,392 | $110.00 | D | 21,003 | D | |
| Common Stock | Jul 15, 2015 | M | 7,764 | $45.07 | A | 28,767 | D | |
| Common Stock | Jul 15, 2015 | S | 7,764 | $110.00 | D | 21,003 | D | |
| Common Stock | Jul 15, 2015 | M | 12,058 | $34.96 | A | 33,061 | D | |
| Common StockF3 | Jul 15, 2015 | S | 12,058 | $110.00 | D | 21,003 | D | |
| Common Stock (restricted) | holding | — | — | — | 27,011 | D | ||
| ESOP Common Stock | holding | — | — | — | 558 | I | Direct | |
| Stock Unit | holding | — | — | — | 29,599 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF4 | $54.53 | Jul 15, 2015 | M | 6,884 | D | Apr 1, 2014 | Apr 1, 2020 | Common Stock | 6,884 | 20,654 | D |
| Stock OptionF4 | $54.53 | Jul 15, 2015 | M | 6,884 | D | Apr 1, 2014 | Apr 1, 2020 | Common Stock | 6,884 | 13,770 | D |
| Stock OptionF5 | $74.29 | Jul 15, 2015 | M | 8,392 | D | Apr 1, 2015 | Apr 1, 2021 | Common Stock | 8,392 | 25,177 | D |
| Stock OptionF6 | $45.07 | Jul 15, 2015 | M | 7,764 | D | Apr 2, 2013 | Apr 2, 2019 | Common Stock | 7,764 | 7,764 | D |
| Stock OptionF7 | $34.96 | Jul 15, 2015 | M | 12,058 | D | Apr 1, 2012 | Apr 1, 2018 | Common Stock | 12,058 | 0 | D |
| Phantom Stock CreditsF8 | $1.00 | holding | — | — | — | — | — | Common Stock | 467 | 467 | D |
| Stock OptionF9 | $102.26 | holding | — | — | — | Apr 1, 2016 | Apr 1, 2022 | Common Stock | 34,241 | 34,241 | D |
Explanation of responses
- F1All transactions were effected pursuant to a Rule 10b5-1 plan.
- F2Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $110.00 and $110.06 per share.
- F3Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $110.00 and $110.05 per share.
- F4Option became exercisable in four equal annual installments, commencing 4/1/2014.
- F5Option became exercisable in four equal annual installments, commencing 4/1/2015.
- F6Option became exercisable in four equal annual installments, commencing 4/2/2013.
- F7Option became exercisable in four equal annual installments, commencing 4/1/2012.
- F8Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, as such time as has been elected by the reporting person.
- F9Option becomes exercisable in four equal annual installments, commencing 4/1/2016.